Show simple item record

dc.contributor.authorRanaware, A.
dc.contributor.authorBanik, K.
dc.contributor.authorDeshpande, V.
dc.contributor.authorPadmavathi, G.
dc.contributor.authorRoy, N.
dc.contributor.authorSethi, G.
dc.contributor.authorFan, L.
dc.contributor.authorKumar, Alan Prem
dc.contributor.authorKunnumakkara, A.
dc.date.accessioned2018-12-13T09:15:09Z
dc.date.available2018-12-13T09:15:09Z
dc.date.created2018-12-12T02:47:00Z
dc.date.issued2018
dc.identifier.citationRanaware, A. and Banik, K. and Deshpande, V. and Padmavathi, G. and Roy, N. and Sethi, G. and Fan, L. et al. 2018. Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer. International Journal of Molecular Science. 19 (8): 2362.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/73030
dc.identifier.doi10.3390/ijms19082362
dc.description.abstract

© 2018 by the authors. Licensee MDPI, Basel, Switzerland. The past few decades have witnessed widespread research to challenge carcinogenesis; however, it remains one of the most important health concerns with the worst prognosis and diagnosis. Increasing lines of evidence clearly show that the rate of cancer incidence will increase in future and will create global havoc, designating it as an epidemic. Conventional chemotherapeutics and treatment with synthetic disciplines are often associated with adverse side effects and development of chemoresistance. Thus, discovering novel economic and patient friendly drugs that are safe and efficacious is warranted. Several natural compounds have proved their potential against this dreadful disease so far. Magnolol is a hydroxylated biphenyl isolated from the root and stem bark of Magnolia tree. Magnolol can efficiently prevent or inhibit the growth of various cancers originating from different organs such as brain, breast, cervical, colon, liver, lung, prostate, skin, etc. Considering these perspectives, the current review primarily focuses on the fascinating role of magnolol against various types of cancers, and the source and chemistry of magnolol and the molecular mechanism underlying the targets of magnolol are discussed. This review proposes magnolol as a suitable candidate that can be appropriately designed and established into a potent anti-cancer drug.

dc.publisherMDPI AG
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleMagnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer
dc.typeJournal Article
dcterms.source.volume19
dcterms.source.number8
dcterms.source.issn1661-6596
dcterms.source.titleInternational Journal of Molecular Science
curtin.departmentCurtin Medical School
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/